Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,396) with videos related to
Page
of 140
Sort By:
Circulation
|
September 18, 2013
C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy
Rishi Puri, Steven E Nissen, Peter Libby, et al.
Nature
|
June 7, 2013
Ice-sheet mass balance and climate change
Edward Hanna, Francisco J Navarro, Frank Pattyn, et al.
BMJ Open
|
May 6, 2022
Health literacy and long-term health outcomes following myocardial infarction: protocol for a multicentre, prospective cohort study (ENHEARTEN study)
Alison Beauchamp, Jason Talevski, Stephen J Nicholls, et al.
American Heart Journal
|
September 15, 2019
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
Kausik K Ray, Stephen J Nicholls, Henry D Ginsberg, et al.
Heart, Lung & Circulation
|
November 16, 2024
Cardiovascular Workforce Sustainability Sector Consultation: Recommendations From an Australian Stakeholder Summit
Celine F Santiago, Lauren C Blekkenhorst, Meng-Ping Hsu, et al.
Diabetes
|
March 31, 2026
Inhibition of miR-181c-5p Rescues Diabetes-Impaired Angiogenesis in Ischemia and Wound Healing
Emma L Solly, Yingjun Luo, Khalia R Primer, et al.
American Journal of Preventive Cardiology
|
July 3, 2026
Obicetrapib safety analysis: Pooled phase 3 clinical trial experience
Adam J Nelson, John Jp Kastelein, Marc Ditmarsch, et al.
Scientific Reports
|
February 10, 2019
A Novel Ruthenium-based Molecular Sensor to Detect Endothelial Nitric Oxide
Achini K Vidanapathirana, Benjamin J Pullen, Run Zhang, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial
Jeroen V Koomen, Hiddo J L Heerspink, Ilse C Schrieks, et al.
Cardiovascular Drugs and Therapy
|
February 22, 2012
ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies
Stephen J Nicholls, Allan Gordon, Jan Johannson, et al.
Page
of 140
Search research articles
Search
Showing results (1091-1100 of 1,396) with videos related to
Sort By:
Page
of 140
Circulation
|
September 18, 2013
C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy
Rishi Puri, Steven E Nissen, Peter Libby, et al.
Nature
|
June 7, 2013
Ice-sheet mass balance and climate change
Edward Hanna, Francisco J Navarro, Frank Pattyn, et al.
BMJ Open
|
May 6, 2022
Health literacy and long-term health outcomes following myocardial infarction: protocol for a multicentre, prospective cohort study (ENHEARTEN study)
Alison Beauchamp, Jason Talevski, Stephen J Nicholls, et al.
American Heart Journal
|
September 15, 2019
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
Kausik K Ray, Stephen J Nicholls, Henry D Ginsberg, et al.
Heart, Lung & Circulation
|
November 16, 2024
Cardiovascular Workforce Sustainability Sector Consultation: Recommendations From an Australian Stakeholder Summit
Celine F Santiago, Lauren C Blekkenhorst, Meng-Ping Hsu, et al.
Diabetes
|
March 31, 2026
Inhibition of miR-181c-5p Rescues Diabetes-Impaired Angiogenesis in Ischemia and Wound Healing
Emma L Solly, Yingjun Luo, Khalia R Primer, et al.
American Journal of Preventive Cardiology
|
July 3, 2026
Obicetrapib safety analysis: Pooled phase 3 clinical trial experience
Adam J Nelson, John Jp Kastelein, Marc Ditmarsch, et al.
Scientific Reports
|
February 10, 2019
A Novel Ruthenium-based Molecular Sensor to Detect Endothelial Nitric Oxide
Achini K Vidanapathirana, Benjamin J Pullen, Run Zhang, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial
Jeroen V Koomen, Hiddo J L Heerspink, Ilse C Schrieks, et al.
Cardiovascular Drugs and Therapy
|
February 22, 2012
ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies
Stephen J Nicholls, Allan Gordon, Jan Johannson, et al.
Page
of 140